Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)

Found 9 hits in this display   

TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridi...)
Affinity DataKi:  13nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridi...)
Affinity DataKi:  13nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridi...)
Affinity DataKi:  13nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridi...)
Affinity DataKi:  210nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridi...)
Affinity DataKi:  210nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridi...)
Affinity DataKi:  210nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridi...)
Affinity DataIC50:  30nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase(Toxoplasma gondii)
Tulane University School Of Medicine

Curated by ChEMBL
LigandPNGBDBM50295553(4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridi...)
Affinity DataIC50:  200nMAssay Description:Inhibition of Toxoplasma gondii recombinant MAPK1 expressed in Escherichia coliMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridi...)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of human recombinant p38alpha assessed as [gamma33P]ATP utilization by microplate scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed